To define the immunoregulatory mechanisms underlying serum IgE levels found in patients with filariasis, we studied polyclonal IgE production by peripheral blood mononuclear cells (PBMC) from 15 patients with filarial infections, with a focus on the role of interleukin4 (IL4) and interferon-gamma (IFN-'y) in the generation and regulation of the response.
Introduction
Human filarial parasites, which affect > 200 million people worldwide, lead to persistent infections that stimulate a broad range of host immune responses. One of these responses, the production of high levels of IgE antibody, is particularly characteristic and has been implicated as being a determinant of both the resistance to infection (1, 2) and the pathogenesis of the various clinical manifestations. Much of the IgE produced is not parasite specific and is therefore felt to represent polyclonal activation of B cells (3) . This induction of IgE by parasitic infections has been shown to be T cell dependent both in animal model systems (4, 5) and in humans (6) . These T cells appear to exert their effect through the production of soluble factors that selectively enhance IgE production by human B cells in vitro, as demonstrated in experiments both with parasite-specific T cell clones (6) and with peripherial blood T cells from patients with severe atopy (7) (8) (9) or the hyperimmunoglobulin-E (HIE)' syndrome (10) .
In murine systems, recent experimental studies to identify the lymphokines involved in regulating the IgE response have indicated a crucial role for interleukin-4 in the generation of IgE and for interferon-gamma (IFN-y) in suppressing this response (1 1) . Similar studies with normal human peripheral blood mononuclear cells (PBMC) have shown that purified human recombinant IL-4 can induce IgE production in unfractionated human PBMC and that recombinant human IFN-'y can inhibit this IL-4-stimulated IgE production (12) . Furthermore, IFN-y has been shown to suppress the excessive ongoing IgE production, both in vitro and in vivo, in patients with the very unusual HIE syndrome (13) .
In the present study, we have examined whether these mechanisms for regulating IgE production initially defined in murine systems and in patients with syndromes associated with abnormal IgE production were also involved in regulating IgE responses in the far more common situation where humans are naturally infected with helminth parasites. Using PBMC from patients with filarial infections caused by Loa loa and Onchocera volvulus, we have demonstrated in these studies that IL-4 and IFN-'y, indeed, play crucial roles in the regulation of the polyclonal IgE responses commonly seen in these infections.
Methods
Patient population. 10 patients with Loa loa and five patients with Onchocerca volvulus were studied (Table I ). All were in good health at the time of study except for the signs and symptoms of their parasite infections. Onchocerciasis was confirmed in four patients by the presence of microfilariae in skin snips; the fifth patient (No. 15) had had documented infection 17 yr previously, but had subsequently cleared the infection. Loa loa infections were documented by (a) microfilariae in the blood (patient Nos. 4 and 13), (b) removal of an adult worm from the skin after treatment (patient Nos. 1, 2, and 9), (c) the occurrence of a migrating worm across the eye (patient Nos. 5 and 7), or (d) satisfying the clinical criteria for loiasis (14) by having Calabar swellings (localized angioedema) and eosinophilia (patient Nos. 3, 6 , and 12). 13 patients (Nos. 1-3 and 5-14) were expatriates who had acquired their infections during the course of their work in endemic areas; patient Nos. 4 and 15 were native to the endemic areas. The majority of patients (Nos. 1-3, 5-7, 12, and 13) were studied before any treatment was given; the remaining received at least one course of therapy before the time of study (either diethycarbamazine or ivermectin) that had not been effective in completely eradicating the infections.
Antigens and mitogens. Brugia malayi filarial antigen (BmA) and Onchocerca volvulus antigen (OvA) were prepared as saline extracts of 1. Abbreviations used in this paper: HIE, hyperimmunoglobulin-E; IFN-,y, interferon-gamma; IL-4, interleukin-4; PBMC, peripheral blood mononuclear cells. Repeat cultures of PBMC on the same patients in separate experiments always gave similar, if not identical, results for spontaneous in vitro IgE production and for stimulation of IgE production by filarial antigens. Spontaneous in vitro IgE production by PBMC from five normal individuals ranged from undetectable to 500 pg/ml in this assay.
ELISA assays for IgM, IgE, and parasite-specific IgG antibody.
IgM in culture supernatants was measured using an enzyme-linked immunosorbent assay described previously (17) . IgE was measured using an avidin-biotin amplified ELISA described previously (18). Serum parasite-specific IgG antibodies to BmA were measured as previously described (16 Correlations ofgroups ofordered data were determined by Spearman's rank correlation.
Results
Serum IgE levels and spontaneous in vitro IgE production in patients with filariasis. 11 of 15 study patients had elevated serum IgE levels which ranged from 483 to 19,817 ng/ml (normals < 350 ng/ml; Table I ). The four patients with normal serum IgE levels (Nos. 8, 9, 14, and 15) had been previously treated for filariasis, and the only remaining evidence ofactive infection in three of those (Nos. 8, 9, and 14) was the persistance of elevated antifilarial antibody titers (normals < 150 U/ml; Table I ); patient No. 15 appeared to have spontaneously cured her infection acquired 17 yr previously. There was a trend (not statistically significant) for patients with normal serum IgE levels to have the lowest antifilarial antibody titers.
Spontaneous IgE production by cultured PBMC from the same patients ranged from < 100 pg/ml to 6.464 ng/ml. Though there was a tendency toward a correlation between levels of serum IgE and spontaneous in vitro IgE production (Table I) , this relationship did not reach statistical significance.
Effect offilarial antigens on in vitro IgE production by PBMC. When the effect of parasite antigen on IgE production in patients with filarial infection was studied in 12 of the 15 patients, 10 of 12 showed a significant increase in the in vitro IgE production when PBMC were stimulated with BmA (for patients with loiasis) or OvA (for patients with onchocerciasis). Among the six patients with loiasis demonstrating a significant increase in IgE production, five showed a dose-dependent response that peaked at 0.001 g/ml ofBmA and was suppressed at higher concentrations (Fig. 1 ). In the sixth patient (No. 12), IgE production was stimulated by doses of BmA as low as 0.001 ug/ml, but peak response was achieved only at a concentration of 1 sponsive to parasite antigen, the antigen-induced IgE production (studied at each individual's peak response) was completely inhibited by anti-IL-4, and in the remaining patient, No. 8, it was significantly inhibited (by 46%; P < 0.05; Fig. 2 ). This effect was dose-dependent in that decreasing the concentration of anti-IL-4 in the presence ofparasite antigen reduced the inhibition of parasite antigen-induced IgE production (data not shown). Addition of normal rabbit sera to parallel cultures at the same dilution as the anti-IL-4 antiserum had no effect on the antigen-induced IgE response.
Effect ofanti-IFN-y on parasite antigen-induced IgE production. The role of IFN-,y in the regulation of antigen-induced IgE responses was studied by culturing PBMC in the presence of both parasite antigen and rabbit anti-IFN-'y. In all 10 parasite antigen-responsive patients, the presence of anti-IFN-y significantly increased IgE production by 33% to 1,238% (Fig. 3) . Control cultures containing normal rabbit PARASITE PARASITE ANTIGEN ANTIGEN + anti-IFN-Y sera (at the same concentration) had no effect on parasite antigen induced IgE production.
Augmentation ofparasite antigen-induced in vitro IgE production by anti-IFN-y was dependent on antigen concentration. Addition of anti-IFN-'y to PBMC cultures containing concentrations of parasite antigen that induced maximal IgE production did not increase further the IgE production in 9 of 10 antigen responsive patients (data not shown); rather, maximal anti-IFN-y augmentation of parasite antigen-induced IgE production occurred at those higher antigen concentrations that actually suppressed IgE production ( Fig. 1 ). This relationship between antigen concentration and the effect of anti-IFN-y on IgE production is illustrated in Fig. 4 , where data from the five loiasis patients whose antigen-induced IgE production had similar dose-response curves ( Fig. 1) are presented. Anti-IFN-,y was unable to augment in vitro IgE production stimulated by 0.001 jIg/ml of BmA, but in the presence ofantigen levels that suppressed IgE production (0.01 and 0.1 ug/ml), anti-IFN-y actually increased in vitro IgE production back to maximal levels (Fig. 4) . In contrast, addition of anti-IFN-y to PBMC cultures without parasite antigen had no effect on spontaneous in vitro IgE production in five of six parasite patients so studied; and in the sixth patient (No. 8), addition of anti-IFN-'y increased IgE production from undetectable to only minimal levels.
Effect of IFN-,y on spontaneous and parasite antigen-induced IgE production by PBMC. To investigate further the effect of IFN-'y on in vitro IgE production, separate experiments were performed in which IFN-,y was added to PBMC cultures containing optimal parasite antigen concentrations for four patients with loiasis (Table II) . Addition of 10-1,000 U/ml of IFN-,y to cultures completely or almost completely inhibited parasite antigen induced IgE production in all four patients. Concentrations of 1,000-100,000 U/ml ofIFN-'y further inhibited in vitro IgE production to levels significantly below that spontaneously released from PBMC cultured in the absence of parasite antigen for three of the four patients.
To determine whether IFN-y could inhibit spontaneous in vitro IgE production in PBMC cultures by itself, separate studies were performed. When IFN-,y was added to unstimulated PBMC cultures of five patients with loiasis, concentrations of IFN-'y as low as 10 U/ml significantly inhibited (P < 0.001) IgE production by an average of 35% (Fig. 5,0 0 ). Inhibition increased with increasing doses, reaching 82% inhibition at 101 U/ml IFN-,y. In contrast, in vitro IgM production was not significantly inhibited by 10 to 1000 U/ml of IFN-y, and at 105 U/ml IFN-,y IgM production was inhibited by only 16% (Fig. 5, 0  0 ).
Discussion
The current understanding of cytokine regulation of IgE production in humans is based largely on results ofexperiments in which recombinant lymphokines were added to cultured lymphocytes from normal or atopic individuals. Whether such findings also pertain to the in vivo generation of IgE in disorders associated with elevated serum levels of IgE is not as antigen-stimulated IgE production in humans. B cell activation and immunoregulation were initially analyzed using in vitro systems of antigen-induced antibody production by cells obtained from subjects immunized with either recall (19) or virgin (20) antigens. Such investigations were later extended to naturally acquired filarial infections by using parasite antigens to induce both total and parasite antigen-specific IgG and IgM production (16) . The present study, using a similar in vitro system, has demonstrated that parasite antigen can also induce polyclonal IgE production at concentrations that are similar to those required for IgG and IgM production (16) and that are several orders of magnitude lower than those optimal for antigen-induced lymphocyte proliferation. Such parasite antigen-stimulated polyclonal IgE production was clearly dose dependent, but while the antigen concentrations needed to induce optimal IgE by PBMC were similar for the majority of filariasis patients (0.01-0.001 tg/ml), peak IgE production occurred at significantly higher parasite antigen concentrations in four others. Such differences may reflect only variable responses of each individual's T lymphocytes to allergens found at different concentrations in the complex preparations of parasite antigen used in this study, and efforts are underway to study the effect of defined/purified (21) or cloned filarial antigens (22) on T and B cell responses.
An interesting observation made in this study was that higher concentrations of parasite antigen suppressed antigeninduced IgE production and that this suppression was reversible with the simultaneous addition of anti-IFN-,y. This finding suggests that concentrations ofparasite antigen that induce optimal IgE production may selectively stimulate antigen-specific T cells to produce primarily Higher concentrations of parasite antigen may stimulate proportionally more IFN-,y production by either the same parasite antigen-specific T cells, by additional CD4' cells that produce predominantly IFN-y, or by T suppressor cells. These results are consistent with those of previous studies of other immunoglobulin isotypes demonstrating that higher concentrations of antigen can suppress immunoglobulin production and that this inhibition is, in part, mediated by T suppressor cells (23) ; those earlier reports did not define the lymphokines mediating such suppression.
While this study has demonstrated an important role for IFN-y in modulating the IgE response to parasite antigens, the role of IFN-a and prostaglandin E2 (shown previously to inhibit IL-4-induced IgE production in normal individuals [ 12] ) in modulating IgE responses to parasite antigens remains to be defined.
This study also demonstrates that parasite antigen-induced in vitro IgE production by PBMC from patients with filariasis is IL-4 dependent. As such, they support similar observations of Nippostrongylus brasiliensis-induced IgE production in infected mice, where in vivo injection of anti-IL-4 completely blocked the IgE response to the parasite (24) . They also support and extend the findings from a recent study in humans in which only the Dermatophagoides spp. (house dust mite)-specific T cell clones that expressed mRNA for IL-4 were capable of inducing IgE production by autologous B cells (25) ; however, even that study failed to demonstrate directly that endogenously produced IL-4 from the antigen-specific clones, in fact, induced the IgE production.
In murine systems, IL-4 may have a role not just in initiating but also in maintaining an established ongoing in vivo IgE response (26) . Whether IL-4 has such a role in humans is less clear. Addition of anti-IL-4 to unstimulated cultures ofPBMC from patients with filariasis (reported in this study) and from HIE patients (unpublished data) failed to inhibit the excessive ongoing IgE production. Whether this finding is a technical artifact resulting from culture conditions, or whether it indicates that the primary role ofIL-4 in humans may be to induce isotype switching from IgM to IgE and not in sustaining the IgE response, remains to be determined. There is evidence that another cytokine, macrophage-derived IL-6, may be important in both the IL-4-dependent IgE induction (27) and in sustaining ongoing immunoglobulin production by acting as a non-isotype-specific, late amplification signal for Ig synthesis by B cells (28).
Our study further indicates that recombinant human IFN-'y, at concentrations of 10-100,000 U/ml, can essentially completely inhibit parasite antigen-induced IgE production in vitro (Table II) . This finding is similar to results seen in murine systems in which in vivo IgE production was inhibited by simultaneous administration of IFN--y and augmented by injection of anti-IFN-'y antibody (24) . Additionally, the data also show that IFN-'y can inhibit the ongoing spontaneous production of IgE in cultures of PBMC from patients with filariasis, whether by inhibiting IgE secreting plasma cells or by inhibiting the IL-4-induced IgE production is uncertain but the latter possibility is less likely for several reasons. First, as mentioned above, spontaneous in vitro IgE production by cultured PBMC from HIE or filariasis patients appears not to be dependent on the ongoing production of IL-4. Second, T cells require a stimulus for cytokine production which is absent in these experiments, except for the presence of IFN-'y. It remains to be determined whether IFN-'y exerts its inhibitory effect directly on plasma cells or indirectly through T cells or macrophages.
The present study thus provides a model of antigen-stimulated IgE production that enables further dissection ofthe network of cellular components and cytokines involved in the regulation of IgE antibody production in humans. This model can be used to assess not only polyclonal IgE production, but also regulation of antigen-specific antibody production; in addition, it should allow one to determine whether IgG subclass production (both total and antigen specific) is also under the influence of regulatory controls similar to those of IgE, as suggested in studies on animal models (29) . Indeed, because elevated serum IgE levels in patients with lymphatic filariasis generally correlate with high serum IgG4 (30) , there is a suggestion that parallel immunoregulatory mechanisms may be at work. Examination of the frequency of parasite-specific T and B lymphocytes, differences in the in vitro responses to parasite antigen by PBMC, and the role of different cytokines in the generation of the IgE response among such patients with filarial parasite infections should provide a greater understanding of the immunoregulatory network underlying not only these, but also other disorders associated with elevated levels of serum IgE.
